Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population.

Autor: Mongale E; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Allen S; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Brew I; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Ludlow-Rhodes A; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Royal N; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Waldron J; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK., Alexander H; Practice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.; Defence Primary Healthcare, UK., Christensen L; The Hepatitis C Trust, 27 Crosby Row, London SE1 3YD, UK., Dorrington K; Gilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK., Milner A; Gilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK., Missen L; Gilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK., Jones A; Gilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK., Troke PJF; Gilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2023 Oct 16; Vol. 6 (1), pp. 100937. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2024).